Merck Gets Nonprescription Approval For Zocor In U.K.
This article was originally published in The Pink Sheet Daily
Executive Summary
MHRA approves Merck’s 10 mg simvastatin tablets to reduce the risk of a first major coronary event in a moderate-risk population. Marketed by McNeil Europe, Zocor Heart-Pro will be the first statin sold without a prescription in the world.